29 results
8-K
EX-99.1
TSVT
2seventy bio Inc
12 Sep 23
2seventy bio Announces Strategic Restructuring to Prioritize Growth of Abecma, Streamline Pipeline Advancement and Preserve Financial Runway
7:13am
officer. “However, the macro environment for oncology cell therapy companies and the near-term headwinds we have seen in our own business have led us
PRE 14A
TSVT
2seventy bio Inc
18 Apr 23
Preliminary proxy
5:21pm
Officer reinforces the independence of the Board of Directors from management, creates an environment that encourages objective oversight … , especially in the current litigious environment and regardless of merit. Limiting concern about personal risk would empower both directors and officers
8-K
EX-1.1
iewqnldjww55o 36qm
18 Nov 22
Entry into a Material Definitive Agreement
4:40pm
424B3
mojykpgcvz
12 May 22
Prospectus supplement
5:10pm
8-K
EX-99.1
4lsp 74bd
12 May 22
2seventy bio Reports First Quarter Financial Results and Recent Operational Progress
4:10pm
DEF 14A
71lsmilhrqrj
26 Apr 22
Definitive proxy
4:11pm
10-K
5agszmv03
22 Mar 22
Annual report
7:09am
8-K
EX-10.1
ebk2loeyd250
16 Mar 22
2seventy bio Secures $170 Million in Private Placement Equity Financing
7:58am
10-Q
nax ho5307a42q82o79
1 Dec 21
Quarterly report
7:08am
8-K
EX-10.5
7qbyzvwibugc
4 Nov 21
Entry into a Material Definitive Agreement
7:24am
8-K
EX-10.4
gfy3z u6e9z18x
4 Nov 21
Entry into a Material Definitive Agreement
7:24am
8-K
EX-10.6
dp6nhoesjkzx8az0
4 Nov 21
Entry into a Material Definitive Agreement
7:24am
8-K
EX-99.1
znofc2dgyogt
4 Nov 21
Entry into a Material Definitive Agreement
7:24am
10-12B/A
EX-10.21
snd6n 1waxqsjx
8 Oct 21
Registration of securities (amended)
4:43pm
10-12B/A
EX-10.22
z8z nf08l79
8 Oct 21
Registration of securities (amended)
4:43pm
10-12B/A
EX-10.2
2zxo78q 0p4y8
8 Oct 21
Registration of securities (amended)
4:43pm